Convalescent plasma treatment reduces mortality rate among COVID-19 patients

The investigators found in a review article of 38 studies with a total of 27,706 COVID-patients, of which 3,262 (2,127 in convalescent plasma-treated (CPT) group and 1,135 in the non-convalescent plasma/control group) patients died, that convalescent plasma treatment is effective in reducing the mortality rate in concomitant treatment for COVID-19 along with antiviral/antimicrobial drugs, steroids and other supportive care and has low incidence of serious adverse events during and after convalescent plasma infusion, which are mostly controllable.

Read more right here:
Convalescent plasma treatment reduces mortality rate among COVID-19 patients